re: #67 danarchy

Their cost/benefit analysis doesn’t quantify a reduction in transmission. That doesn’t mean it’s not there, just that they can’t quantify it. Reducing hundreds of hospitalizations among the younger age groups, and reducing transmission (unquantified) is worth getting a booster.